Clinical Trial Update: Effect of Arginine- and Glutamine-based Oral Formulations on Salivary Biomarkers and Clinical Severity of Radiation-induced Oral Mucositis in Head and Neck Cancer: A Randomized Controlled Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating arginine- and glutamine-based oral formulations on salivary biomarkers and clinical severity of radiation-induced oral mucos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis
• Radiation-induced Oral Mucositis

Drugs mentioned

• Arginine-based oral formulation (L-Arginine)
• Glutamine-based oral formulation (L-Glutamine)

Snippet

Sponsor: Ain Shams University | Conditions: Radiation Induced Oral Mucositis, Oral Mucositis | Phase 2 | Status: COMPLETED